PCMT1
PCMT1 (protein-L-isoaspartate (D-aspartate) O-methyltransferase) is a cytosolic enzyme that initiates the repair of damaged proteins. It methylates L-isoaspartyl and D-aspartyl residues that arise spontaneously in aging peptides and proteins. Browse Assay Genie's current range of PCMT1 research reagents below, or read on for the biology behind the target.
PCMT1 initiates the repair of damaged proteins by catalysing methyl esterification of L-isoaspartyl and D-aspartyl residues. These abnormal residues are produced by spontaneous isomerisation and racemisation of L-aspartyl and L-asparaginyl residues in aging peptides and proteins. By recognising them and converting them back to the normal L-aspartyl form, the enzyme helps to restore damaged proteins. The reaction follows spontaneous deamidation, and the enzyme is classed as a type II protein carboxyl methyltransferase.
UniProt lists a number of substrates on which PCMT1 acts: EIF4EBP2, microtubule-associated protein 2, calreticulin, clathrin light chains a and b, ubiquitin C-terminal hydrolase isozyme L1, phosphatidylethanolamine-binding protein 1, stathmin, beta-synuclein and alpha-synuclein. The protein localises to the cytosol. It belongs to the methyltransferase superfamily and the L-isoaspartyl/D-aspartyl protein methyltransferase family, and HGNC places the gene in the 7BS protein methyltransferases group, within the isoaspartate methyltransferases. Mouse and rat both have a Pcmt1 ortholog, which is relevant to researchers planning in vivo work.
The PCMT1 gene is reported to produce alternatively spliced transcript variants encoding multiple isoforms. NCBI Gene notes that the encoded protein may play a protective role in the pathogenesis of Alzheimer's disease. Single nucleotide polymorphisms in the gene have also been associated with spina bifida and premature ovarian failure, making PCMT1 a point of interest for studies of protein ageing and damage.
PCMT1 recognises L-isoaspartyl and D-aspartyl residues and starts their conversion back to L-aspartyl, making it a core enzyme for studying repair of aged proteins.
The encoded protein may play a protective role in Alzheimer's disease, and it acts on alpha-synuclein and beta-synuclein, among other substrates.
Single nucleotide polymorphisms in the PCMT1 gene have been associated with spina bifida and premature ovarian failure.
As an EC 2.1.1.77 type II protein carboxyl methyltransferase, PCMT1 is a model for studying methyl esterification of abnormal aspartyl residues.
PCMT1 initiates the repair of damaged proteins. It catalyses methyl esterification of L-isoaspartyl and D-aspartyl residues formed by spontaneous isomerisation and racemisation of aspartyl and asparaginyl residues, helping to return them to the normal L-aspartyl form.
No aliases or previous symbols are listed in the HGNC data. The full name is protein-L-isoaspartate (D-aspartate) O-methyltransferase, and its enzyme classification is EC 2.1.1.77. NCBI Gene reports alternatively spliced transcript variants that encode multiple isoforms.
Mouse and rat each have a Pcmt1 ortholog; check the datasheet of any product for its validated reactivity. NCBI Gene notes a possible protective role in Alzheimer's disease, and gene variants have been associated with spina bifida and premature ovarian failure.
Substrates of PCMT1 named in UniProt, including synucleins, stathmin and calreticulin, along with other protein repair and neurodegeneration targets.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P22061; product specifications from Assay Genie datasheets.